Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DXRNASDAQ:ECORNASDAQ:POCINASDAQ:SSKN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXRDaxor$9.25+4.2%$7.77$6.55▼$10.00$44.74M-0.135,926 shs3,745 shsECORelectroCore$5.73+6.9%$5.80$4.47▼$19.49$42.52M0.9296,010 shs120,660 shsPOCIPrecision Optics$4.74+5.8%$4.31$3.47▼$6.59$36.34M0.2115,124 shs14,395 shsSSKNSTRATA Skin Sciences$2.43-0.8%$2.57$2.10▼$3.80$10.14M0.713,232 shs6,374 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXRDaxor+4.17%+14.20%+23.83%+15.63%+7.06%ECORelectroCore+6.90%+12.80%-15.86%-59.36%-11.98%POCIPrecision Optics+5.80%+10.49%+6.04%+0.85%-25.00%SSKNSTRATA Skin Sciences+1.46%-1.66%-7.25%-5.08%-31.57%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDXRDaxor3.6446 of 5 stars3.53.00.00.01.53.30.0ECORelectroCore2.3065 of 5 stars3.52.00.00.01.72.50.6POCIPrecision Optics0.1146 of 5 stars0.03.00.00.00.00.80.0SSKNSTRATA Skin Sciences2.3996 of 5 stars3.53.00.00.00.61.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDXRDaxor 3.00Buy$25.00170.27% UpsideECORelectroCore 3.00Buy$25.50345.03% UpsidePOCIPrecision Optics 0.00N/AN/AN/ASSKNSTRATA Skin Sciences 3.00Buy$6.00146.91% UpsideCurrent Analyst Ratings BreakdownLatest SSKN, DXR, ECOR, and POCI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/17/2025DXRDaxorAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$24.75 ➝ $25.003/13/2025ECORelectroCoreLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$28.00 ➝ $26.003/13/2025ECORelectroCoreHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00(Data available from 6/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDXRDaxor$2.13M21.00N/AN/AN/A∞ECORelectroCore$26.46M1.61N/AN/A$1.24 per share4.62POCIPrecision Optics$17.63M2.06N/AN/A$1.49 per share3.18SSKNSTRATA Skin Sciences$33.62M0.30N/AN/A$3.65 per share0.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDXRDaxorN/AN/A0.00∞N/AN/AN/AN/AN/AECORelectroCore-$18.83M-$1.56N/AN/AN/A-54.40%-154.45%-69.16%8/6/2025 (Estimated)POCIPrecision Optics-$2.95M-$0.89N/A∞N/A-21.46%-39.17%-22.93%N/ASSKNSTRATA Skin Sciences-$10.83M-$2.27N/AN/AN/A-28.72%-69.33%-17.55%8/13/2025 (Estimated)Latest SSKN, DXR, ECOR, and POCI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q3 2025POCIPrecision OpticsN/A-$0.30N/A-$0.30N/A$4.19 million5/14/2025Q1 2025SSKNSTRATA Skin Sciences-$0.56-$0.58-$0.02-$0.58$7.28 million$6.81 million5/7/2025Q1 2025ECORelectroCore-$0.56-$0.47+$0.09-$0.47$6.93 million$6.72 million3/27/2025Q4 2024SSKNSTRATA Skin Sciences-$0.40-$1.13-$0.73-$1.13$9.03 million$33.56 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDXRDaxor$0.030.32%N/AN/AN/AECORelectroCoreN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/ASSKNSTRATA Skin SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDXRDaxorN/AN/AN/AECORelectroCoreN/A2.121.87POCIPrecision Optics0.171.220.62SSKNSTRATA Skin Sciences1.621.130.94Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDXRDaxor1.34%ECORelectroCore26.74%POCIPrecision Optics13.71%SSKNSTRATA Skin Sciences32.43%Insider OwnershipCompanyInsider OwnershipDXRDaxor59.00%ECORelectroCore19.70%POCIPrecision Optics12.99%SSKNSTRATA Skin Sciences39.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDXRDaxor374.84 million1.98 millionNot OptionableECORelectroCore507.42 million5.35 millionNot OptionablePOCIPrecision Optics807.67 million5.33 millionNot OptionableSSKNSTRATA Skin Sciences1204.17 million2.54 millionNot OptionableSSKN, DXR, ECOR, and POCI HeadlinesRecent News About These CompaniesSTRATA Skin Sciences Gains CPT Code Expansion For Excimer Laser Use In Skin Inflammatory DiseasesMay 21, 2025 | nasdaq.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2025 Earnings Call TranscriptMay 16, 2025 | insidermonkey.comSTRATA Skin Sciences, Inc. (SSKN) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comSTRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 14, 2025 | globenewswire.com3SSKN : A Peek at Strata Skin Sciences's Future EarningsMay 13, 2025 | benzinga.comStrata Skin Sciences Inc (SSKN) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 13, 2025 | finance.yahoo.comSTRATA Skin Sciences to Join D. Boral Capital’s Inaugural Global Conference in NYCMay 11, 2025 | msn.comSTRATA Skin Sciences to Announce Q1 2025 Financial Results and Host Investor CallMay 11, 2025 | msn.comSTRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate UpdateMay 9, 2025 | seekingalpha.comSTRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global ConferenceMay 8, 2025 | globenewswire.comSTRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate UpdateMay 7, 2025 | globenewswire.comStrata Skin Sciences price target lowered to $14 from $16 at LadenburgMarch 31, 2025 | markets.businessinsider.comEarnings call transcript: STRATA Skin Sciences Q4 2024 revenue rises 10%March 29, 2025 | uk.investing.comSTRATA Skin Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS LagsMarch 29, 2025 | finance.yahoo.comSTRATA SKIN SCIENCES Earnings Results: $SSKN Reports Quarterly EarningsMarch 29, 2025 | nasdaq.comStrata Skin Sciences (SSKN) Gets a Buy from Maxim GroupMarch 29, 2025 | markets.businessinsider.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | insidermonkey.comSTRATA Skin Sciences Reports Strong Q4 Growth and Strategic ProgressMarch 29, 2025 | msn.comQ4 2024 STRATA Skin Sciences Inc Earnings CallMarch 28, 2025 | finance.yahoo.comStrata Skin Sciences reports Q4 EPS ($1.18), consensus (40c)March 28, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesNextracker’s Solar Surge: Will It Shatter Its All-Time High?By Thomas Hughes | May 18, 2025View Nextracker’s Solar Surge: Will It Shatter Its All-Time High?Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith?By Jeffrey Neal Johnson | May 22, 2025View Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith?Symbotic Gets Big Earnings Lift: Is the Stock Investable Again?By Leo Miller | May 16, 2025View Symbotic Gets Big Earnings Lift: Is the Stock Investable Again?Broadcom Earnings Preview: AVGO Stock Near Record HighsBy Leo Miller | June 3, 2025View Broadcom Earnings Preview: AVGO Stock Near Record Highse.l.f. Beauty Sees Record Surge After Earnings, Rhode DealBy Leo Miller | May 30, 2025View e.l.f. Beauty Sees Record Surge After Earnings, Rhode DealSSKN, DXR, ECOR, and POCI Company DescriptionsDaxor NASDAQ:DXR$9.25 +0.37 (+4.17%) As of 06/6/2025 03:25 PM EasternDaxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.electroCore NASDAQ:ECOR$5.73 +0.37 (+6.90%) Closing price 06/6/2025 04:00 PM EasternExtended Trading$5.73 0.00 (0.00%) As of 06/6/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Precision Optics NASDAQ:POCI$4.72 +0.24 (+5.45%) As of 06/6/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.STRATA Skin Sciences NASDAQ:SSKN$2.42 -0.03 (-1.39%) As of 06/6/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/02 - 06/06 This Banking Giant Just Got a $90 Price Target Upgrade Broadcom Slides on Solid Earnings, AI Outlook Still Strong The Market’s Silent Warning: What Bonds and Gold Reveal MongoDB Affirms Outlook and Accelerates Stock Price Reversal Are NVIDIA's Ethernet Wins Signs of Hope or Horror for Arista? AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio? Why Visa's Innovation Engine Keeps It a Top Portfolio Pick Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
